Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis

International Journal of Cardiology

Volumn 144, Issue 3, 2010, Pages 373-378

  Berger, Rolf M F ^a   Beghetti, Maurice ^b   Galiè, Nazzareno ^c   Gatzoulis, Michael A ^d   Granton, John ^e   Lauer, Andrea ^f   Chiossi, Eleonora ^f   Landzberg, Michael ^g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Children's Hospital of Geneva   (Switzerland)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f ACTELION PHARMACEUTICALS LTD   (Switzerland)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Atrial septal defect; BREATHE 5; Eisenmenger's syndrome; Pulmonary arterial hypertension; Ventricular septal defect

Indexed keywords

BOSENTAN; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG WITHDRAWAL; EISENMENGER COMPLEX; EXERCISE; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LIVER FUNCTION TEST; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADULT; ANTIHYPERTENSIVE AGENTS; BOSTON; CANADA; DOUBLE-BLIND METHOD; EISENMENGER COMPLEX; EXERCISE; FEMALE; GREAT BRITAIN; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; ITALY; MALE; MIDDLE AGED; NETHERLANDS; ONTARIO; OXIMETRY; PULMONARY CIRCULATION; PULMONARY WEDGE PRESSURE; SULFONAMIDES; SWITZERLAND; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 77957860787     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.04.037     Document Type: Article

References (21)

1. W. Vongpatanasin, M.E. Brickner, L.D. Hillis, and R.A. Lange The Eisenmenger syndrome in adults Ann Intern Med 128 1998 745 755
2. G.P. Diller, and M.A. Gatzoulis Pulmonary vascular disease in adults with congenital heart disease Circulation 115 2007 1039 1050
3. J.I. Hoffman, A.M. Rudolph, and M.A. Heymann Pulmonary vascular disease with congenital heart lesions: pathologic features and causes Circulation 64 1981 873 877
4. M. Rabinovitch It all begins with EVE (endogenous vascular elastase) Isr J Med Sci 32 1996 803 810
5. P. Wood The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt Br Med J 2 1958 701 709 755-762
6. E.B. Berman, and R.J. Barst Eisenmenger's syndrome: current management Prog Cardiovasc Dis 45 2002 129 138
7. J. Deanfield, E. Thaulow, and C. Warnes Management of grown up congenital heart disease Eur Heart J 24 2003 1035 1084
8. G.P. Diller, K. Dimopoulos, and D. Okonko Exercise intolerance in adult congenital heart disease. Comparative severity, correlates, and prognostic implication Circulation 112 2005 828 835
9. M.E. Van Albada, and R.M. Berger Pulmonary arterial hypertension in congenital cardiac disease - the need for refinement of the Evian-Venice classification Cardiol Young 18 2008 10 17
10. N. Galiè Classification of patients with congenital systemic-to-pulmonary shunts associated with pulmonary arterial hypertension: current status and future directions M Beghetti, RJ Barst, R Naeije, LJ Rubin, Pulmonary arterial hypertension related to congenital heart disease. Munich, Elsevier Urban and Fischer 2006 11 17
11. G.P. Diller, K. Dimopoulos, and C.S. Broberg Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study Eur Heart J 27 2006 1737 1742
12. K. Niwa, J.K. Perloff, S. Kaplan, J.S. Child, and P.D. Miner Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart J Am Coll Cardiol 34 1999 223 232
13. W.J. Cantor, D.A. Harrison, and J.S. Moussadji Determinants of survival and length of survival in adults with Eisenmenger syndrome Am J Cardiol 84 1999 677 681
14. N. Galiè, M. Beghetti, and M.A. Gatzoulis Bosentan therapy in patients with Eisenmenger syndrome. A multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54
15. R.N. Channick, G. Simonneau, and O. Sitbon Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study Lancet 358 2001 1119 1123 (Pubitemid 32971843)
16. S.C. Apostolopoulou, A. Manginas, D.V. Cokkinos, and S. Rammos Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and hemodynamics status of patients with PAH related to CHD Heart 91 2005 1447 1452
17. N. Galiè, A. Torbicki, and R. Barst Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur Heart J 25 2004 2243 2278
18. M. Yoshibayashi, K. Nishioka, and K. Nakao Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation Circulation 84 1991 2280 2285
19. G.G. Pietra, F. Capron, and S. Stewart Pathologic assessment of vasculopathies in pulmonary hypertension J Am Coll Cardiol 43 2004 25S 32S
20. W.E. Hopkins, L.L. Ochoa, G.W. Richardson, and E.P. Trulock Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome J Heart Lung Transplant 15 1996 100 105
21. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150